Myeloid Dysplastic Syndrome
1 clinical trials · Condition
◉ Watch Myeloid Dysplastic Syndrome
| Record | Firm | Date |
|---|---|---|
| Guadecitabine Extension Study (NCT03603964) | Astex Pharmaceuticals, Inc. | 2018-07-18 |
Track Myeloid Dysplastic Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.